25 May 2013
Keywords: btg, collegium, develop, new, asthma, drug, london
Article | 05 September 2005
London, UK-based medical innovations firm, BTG, and USA-headquartered Collegium Pharmaceutical have signed a joint collaboration agreement to develop CP-141, a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.